Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001628280-25-054270

EVP, GC & Business Development sold 20,916 shares at $12.00 ($250,992)

  • EVP, GC & Business Development acquired 8,977 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Olivo Alicia C EVP, GC & Business Development 2025-11-25 Option exercise 10b5-1 +8,977 $10.05 $90,219 51,999 D: show line 1 in the form
Olivo Alicia C EVP, GC & Business Development 2025-11-25 Sale 10b5-1 −20,916 $12.00 $250,992 31,083 D: show line 2 in the form
Open-market sales · 20,916 sh · avg $12.00 · $250,992

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Olivo Alicia C EVP, GC & Business Development 2025-11-25 Option exercise · Stock Option (Right to Buy) 10b5-1 −8,977 46,355 D: show line 3 in the form
Loading xslF345X05/wk-form4_1764364698.xml…